Review: Approved treatments since 2018
Posted: Wed Jul 27, 2022 1:22 am
Here there is a recent review about the status of MS treatments.
https://link.springer.com/article/10.10 ... 22-00939-9
It deals with:
- Diroximel fumarate
- Siponimod
- Ozanimod
- Ponesimod
- Ocrelizumab
- Ofatumumab
And some information about some others close to approval:
- Ublituximab
- Evobrutinib
- Tolebrutinib
- Remibrutinib
- Fenebrutinib
https://link.springer.com/article/10.10 ... 22-00939-9
It deals with:
- Diroximel fumarate
- Siponimod
- Ozanimod
- Ponesimod
- Ocrelizumab
- Ofatumumab
And some information about some others close to approval:
- Ublituximab
- Evobrutinib
- Tolebrutinib
- Remibrutinib
- Fenebrutinib